You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MOR 202

Showing 1 - 25 of 190
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Membranous Nephropathy Trial in Bergamo, Ranica (MOR202)

Recruiting
  • Membranous Nephropathy
  • Bergamo, BG, Italy
  • +1 more
Mar 4, 2022

Glomerulonephritis, Membranous Nephropathy, antiPLA2R Positive Trial in Worldwide (MOR202)

Active, not recruiting
  • Glomerulonephritis
  • +2 more
  • Tbilisi, Georgia
  • +24 more
Aug 23, 2022

Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

Recruiting
  • Antibody-mediated Rejection
  • Vienna, Austria
  • +1 more
Aug 23, 2022

Glomerulonephritis, Membranous, antiPLA2R Positive Trial in Worldwide (MOR202)

Completed
  • Glomerulonephritis, Membranous
  • antiPLA2R Positive
  • Azusa, California
  • +44 more
Dec 12, 2022

Multiple Myeloma Trial in Austria, Germany (MOR03087 phase 1 dose escalation, MOR03087, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • MOR03087 phase 1 dose escalation
  • +4 more
  • Vienna, Austria
  • +9 more
Nov 12, 2021

Immunoglobulin A (IgA) Nephropathy Trial in Worldwide (Felzartamab, Placebo)

Recruiting
  • Immunoglobulin A (IgA) Nephropathy
  • Oxnard, California
  • +59 more
Dec 12, 2022

Coronary Artery Disease Trial in Worldwide (Percutaneous coronary intervention)

Active, not recruiting
  • Coronary Artery Disease
  • Percutaneous coronary intervention
  • Epping, Australia
  • +51 more
Dec 8, 2021

Alcohol Use Disorder Trial (Detoxification Program, PKAB, CFN)

Not yet recruiting
  • Alcohol Use Disorder
  • Detoxification Program
  • +2 more
  • (no location specified)
Jul 13, 2023

Mucopolysaccharidosis IV Type A, Morquio A Syndrome, MPS IVA Trial in Worldwide (Vimizim® (elosulfase alfa))

Active, not recruiting
  • Mucopolysaccharidosis IV Type A
  • +2 more
  • Vimizim® (elosulfase alfa)
  • Phoenix, Arizona
  • +78 more
Dec 23, 2022

Metabolic Syndrome Trial in Québec (INV-202, Placebo)

Completed
  • Metabolic Syndrome
  • Québec, Quebec, Canada
    Syneos Health Clinique Inc
Oct 3, 2022

Duchenne Muscular Dystrophy Trial in Little Rock (RGX-202)

Recruiting
  • Duchenne Muscular Dystrophy
  • RGX-202
  • Little Rock, Arkansas
    Arkansas Children's Hospital
Jan 12, 2023

Obesity, Metabolic Syndrome Trial (INV-202, Placebo)

Not yet recruiting
  • Obesity
  • Metabolic Syndrome
  • (no location specified)
Jun 7, 2023

Healthy Volunteers, Mild to Moderate Psoriasis Trial in Manchester (Placebo, AX-202)

Recruiting
  • Healthy Volunteers
  • Mild to Moderate Psoriasis
  • Placebo
  • AX-202
  • Manchester, Wythenshawe, United Kingdom
    Medicines Evaluation Unit
Jul 19, 2023

NASH - Nonalcoholic Steatohepatitis Trial in Worldwide (VK2809, Placebos)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Birmingham, Alabama
  • +107 more
Mar 1, 2022

NSCLC Trial in Worldwide (MORAb-202)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Lone Tree, Colorado
  • +21 more
Jan 17, 2023

Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on

Not yet recruiting
  • Influenza, Human
  • +4 more
  • aH5N8c on Day 1
  • +4 more
  • Cullman, Alabama
  • +8 more
May 15, 2023

Healthy Trial (ILB-202, Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
May 2, 2023

Jansky-Bielschowsky Disease, Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 Trial in Worldwide (BMN 190,

Completed
Has Results
  • Jansky-Bielschowsky Disease
  • +4 more
  • BMN 190
  • Intracerebroventricular (ICV) access device
  • Columbus, Ohio
  • +3 more
Jul 28, 2022

Pulmonary Arterial Hypertension Trial (Treprostinil Palmitil, Placebo)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Treprostinil Palmitil
  • Placebo
  • (no location specified)
Dec 6, 2022

Tumors, Ovarian Trial in Worldwide (MORAb-202, Paclitaxel, Pegylated Liposomal Doxorubicin (PLD))

Not yet recruiting
  • Neoplasms, Ovarian
  • Orange, California
  • +38 more
Nov 4, 2022

Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases Trial in Japan (Edwards EWJ-202 Transcatheter

Recruiting
  • Tricuspid Valve Regurgitation
  • +2 more
  • Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System
  • Kitakyushu-shi, Fukuoka, Japan
  • +6 more
Feb 27, 2023

Colorectal Cancer, Metastatic Colon Cancer Trial (Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab, Placebo + FOLFIRI +

Not yet recruiting
  • Colorectal Cancer
  • Metastatic Colon Cancer
  • Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab
  • Placebo + FOLFIRI + Bevacizumab
  • (no location specified)
Aug 1, 2023

Analgesia, Abuse Opioids, Pain Trial in Nashville (Buccal Buprenorphine 300 mcg, Buccal Buprenorphine 600 mcg, Buccal

Not yet recruiting
  • Analgesia
  • +2 more
  • Buccal Buprenorphine 300 mcg
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 8, 2023

Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)

Recruiting
  • Human Papilloma Virus
  • +3 more
  • Chicago, Illinois
    University of Chicago
Aug 11, 2022

Diabetic Kidney Disease Trial (INV-202, Placebo)

Not yet recruiting
  • Diabetic Kidney Disease
  • (no location specified)
Aug 22, 2022